Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: Implications for vaccine design

Proceedings of the National Academy of Sciences of the United States of America

Volumn 92, Issue 13, 1995, Pages 5845-5849

  Thomson, Scott A ^a   Khanna, Rajiv ^a   Gardner, Joy ^a   Burrows, Scott R ^a   Coupar, Barbara ^b   Moss, Denis J ^a   Suhrbier, Andreas ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b AUSTRALIAN ANIMAL HEALTH LABORATORY   (Australia)

Author keywords

antigen presentation; cytotoxic T lymphocytes

Indexed keywords

ANTIGEN; EPITOPE; HYBRID PROTEIN; RECOMBINANT PROTEIN; VIRUS VACCINE;

ANTIGEN PRESENTATION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DNA FLANKING REGION; DNA SEQUENCE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; VACCINE PRODUCTION; VACCINIA VIRUS; VIRUS RECOMBINANT;

AMINO ACID SEQUENCE; ANTIGENS, VIRAL; CLONE CELLS; COMPARATIVE STUDY; DNA PRIMERS; DNA-BINDING PROTEINS; DRUG DESIGN; EPITOPES; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HLA ANTIGENS; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMAN; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, SYNTHETIC; VACCINIA VIRUS; VIRAL VACCINES;

VACCINIA; VACCINIA VIRUS;

EID: 0028998731     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.92.13.5845     Document Type: Article

References (34)